Log In
Print this Print this

239512 (GSK239512)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionHistamine H3 antagonist
Molecular Target Histamine H3 receptor (HRH3)
Mechanism of ActionHistamine H2 receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today